Table 2.

Global population coverage of the PP13138R vaccine for HLA I and II alleles.

Population/area	Class I			Class II
	Coverage a	Average_hit b	Pc90 c	Coverage a	Average_hit b	Pc90 c
Central Africa	31.89%	0.82	0.15	75.00%	1.62	0.4
Central America	1.40%	0.01	0.1	98.31%	5.36	3.48
East Africa	40.83%	1.15	0.17	83.43%	2.16	0.6
East Asia	73.63%	2.38	0.38	67.03%	2.55	0.3
Europe	65.15%	2.14	0.29	69.48%	2.29	0.33
North Africa	46.50%	1.12	0.19	73.52%	2.37	0.38
North America	69.39%	2.32	0.33	86.44%	3.7	0.74
Northeast Asia	81.17%	2.39	0.53	90.13%	3.72	1.01
Oceania	66.73%	1.82	0.3	93.51%	3.83	1.2
South America	45.62%	1.51	0.18	90.26%	4.42	1.05
South Asia	52.68%	0.91	0.21	66.30%	2.23	0.3
Southeast Asia	79.95%	2.56	0.5	81.79%	2.62	0.55
Southwest Asia	47.28%	1.11	0.19	68.41%	2.47	0.32
West Africa	49.18%	1.37	0.2	85.86%	2.32	0.71
West Indies	41.98%	1.09	0.17	72.44%	2.18	0.36
World	67.14%	2.15	0.3	73.08%	2.64	0.37
Average	52.42	1.49	0.25	79.69	2.9	0.76

^aprojected population coverage.

^baverage number of epitope hits/HLA combinations recognized by the population.

^cminimum number of epitope hits/HLA combinations recognized by 90% of the population.